Legacy Wealth Asset Management, LLC
Source: SEC Form 13F · as of Mar 2026Legacy Wealth Asset Management, LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $14.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$14.0M
| Company | Shares | Value |
|---|---|---|
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 165,803 | $3.1M |
| LLYELI LILLY & Co | 2,110 | $1.9M |
| GMABGenmab A/S | 38,680 | $1.0M |
| GILDGILEAD SCIENCES, INC. | 7,445 | $1.0M |
| AMGNAMGEN INC | 2,631 | $926K |
| ARGXARGENX SE | 1,229 | $897K |
| BMYBRISTOL MYERS SQUIBB CO | 13,147 | $797K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,495 | $668K |
| ABTABBOTT LABORATORIES | 5,886 | $604K |
| ZTSZoetis Inc. | 4,798 | $567K |
| LNTHLantheus Holdings, Inc. | 7,465 | $566K |
| ZLABZai Lab Ltd | 24,925 | $469K |
| ICLRICON plc | 2,866 | $317K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 748 | $247K |
| HALOHALOZYME THERAPEUTICS, INC. | 3,827 | $247K |
| ELANElanco Animal Health Inc | 9,902 | $237K |
| IDXXIDEXX LABORATORIES INC /DE | 376 | $211K |
| GMOptec International, Inc. | 2,754 | $205K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.